skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model
The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model

Zmurko, Joanna ; Marques, Rafael E ; Schols, Dominique ; Verbeken, Erik ; Kaptein, Suzanne J F ; Neyts, Johan Powers, Ann M

PLoS neglected tropical diseases, 2016-05, Vol.10 (5), p.e0004695-e0004695 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
2
CYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents
CYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents
Material Type:
Artigo 		Adicionar ao Meu Espaço

CYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents

Yin, Lina ; Hu, Qingzhong

Nature reviews. Urology, 2014-01, Vol.11 (1), p.32-42 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders

Chayama, Kazuaki ; Takahashi, Shoichi ; Toyota, Joji ; Karino, Yoshiyasu ; Ikeda, Kenji ; Ishikawa, Hiroki ; Watanabe, Hideaki ; McPhee, Fiona ; Hughes, Eric ; Kumada, Hiromitsu

Hepatology (Baltimore, Md.), 2012-03, Vol.55 (3), p.742-748 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
4
Angiotensin‐converting enzyme inhibitor works as a scar formation inhibitor by down‐regulating Smad and TGF‐β‐activated kinase 1 (TAK1) pathways in mice
Angiotensin‐converting enzyme inhibitor works as a scar formation inhibitor by down‐regulating Smad and TGF‐β‐activated kinase 1 (TAK1) pathways in mice
Material Type:
Artigo 		Adicionar ao Meu Espaço

Angiotensin‐converting enzyme inhibitor works as a scar formation inhibitor by down‐regulating Smad and TGF‐β‐activated kinase 1 (TAK1) pathways in mice

Tan, Wei‐Qiang ; Fang, Qing‐Qing ; Shen, Xiao Z ; Giani, Jorge F ; Zhao, Tuantuan V ; Shi, Peng ; Zhang, Li‐Yun ; Khan, Zakir ; Li, You ; Li, Liang ; Xu, Ji‐Hua ; Bernstein, Ellen A ; Bernstein, Kenneth E

British journal of pharmacology, 2018-11, Vol.175 (22), p.4239-4252 [Periódico revisado por pares]

England: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
5
Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy: The D: A: D Study
Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy: The D: A: D Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor–Based Combination Antiretroviral Therapy: The D: A: D Study

Bruyand, Mathias ; Ryom, Lene ; Shepherd, Leah ; Fatkenheuer, Gerd ; Grulich, Andrew ; Reiss, Peter ; de Wit, Stéphane ; d´Arminio Monforte, Antonella ; Furrer, Hansjakob ; Pradier, Christian ; Lundgren, Jens ; Sabin, Caroline

Journal of acquired immune deficiency syndromes (1999), 2015-04, Vol.68 (5), p.568-577 [Periódico revisado por pares]

United States: Copyright Wolters Kluwer Health, Inc. All rights reserved

Texto completo disponível

Citações Citado por
6
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Legendre, C.M ; Licht, C ; Muus, P ; Greenbaum, L.A ; Babu, S ; Bedrosian, C ; Bingham, C ; Cohen, D.J ; Delmas, Y ; Douglas, K ; Eitner, F ; Feldkamp, T ; Fouque, D ; Furman, R.R ; Gaber, O ; Herthelius, M ; Hourmant, M ; Karpman, D ; Lebranchu, Y ; Mariat, C ; Menne, J ; Moulin, B ; Nürnberger, J ; Ogawa, M ; Remuzzi, G ; Richard, T ; Sberro-Soussan, R ; Severino, B ; Sheerin, N.S ; Trivelli, A ; Zimmerhackl, L.B ; Goodship, T ; Loirat, C

The New England journal of medicine, 2013-06, Vol.368 (23), p.2169-2181 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
TNF-α inhibitor–induced psoriasis: A decade of experience at the Cleveland Clinic
TNF-α inhibitor–induced psoriasis: A decade of experience at the Cleveland Clinic
Material Type:
Artigo 		Adicionar ao Meu Espaço

TNF-α inhibitor–induced psoriasis: A decade of experience at the Cleveland Clinic

Mazloom, Sean E. ; Yan, Di ; Hu, Jeffery Z. ; Ya, Jason ; Husni, M. Elaine ; Warren, Christine B. ; Fernandez, Anthony P.

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.1590-1598 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer

Jänne, Pasi A ; Baik, Christina ; Su, Wu-Chou ; Johnson, Melissa L ; Hayashi, Hidetoshi ; Nishio, Makoto ; Kim, Dong-Wan ; Koczywas, Marianna ; Gold, Kathryn A ; Steuer, Conor E ; Murakami, Haruyasu ; Yang, James Chih-Hsin ; Kim, Sang-We ; Vigliotti, Michele ; Shi, Rong ; Qi, Zhenhao ; Qiu, Yang ; Zhao, Lihui ; Sternberg, David ; Yu, Channing ; Yu, Helena A

Cancer discovery, 2022-01, Vol.12 (1), p.74-89

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
9
Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada
Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

Bourgi, Kassem ; Jenkins, Cathy A ; Rebeiro, Peter F ; Palella, Frank ; Moore, Richard D ; Altoff, Keri N ; Gill, John ; Rabkin, Charles S ; Gange, Stephen J ; Horberg, Michael A ; Margolick, Joseph ; Li, Jun ; Wong, Cherise ; Willig, Amanda ; Lima, Viviane D ; Crane, Heidi ; Thorne, Jennifer ; Silverberg, Michael ; Kirk, Gregory ; Mathews, William C ; Sterling, Timothy R ; Lake, Jordan ; Koethe, John R

Journal of the International AIDS Society, 2020-04, Vol.23 (4), p.e25484-n/a [Periódico revisado por pares]

Switzerland: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
10
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study
Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study

Meric-Bernstam, Funda ; Bahleda, Rastislav ; Hierro, Cinta ; Sanson, Marc ; Bridgewater, John ; Arkenau, Hendrik-Tobias ; Tran, Ben ; Kelley, Robin Kate ; Park, Joon Oh ; Javle, Milind ; He, Yaohua ; Benhadji, Karim A ; Goyal, Lipika

Cancer discovery, 2022-02, Vol.12 (2), p.402-415

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (752.646)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (782.713)
  2. magazinearticle  (270)
  3. Book Chapters  (46)
  4. Anais de Congresso  (31)
  5. Web Resources  (17)
  6. Newsletter Articles  (11)
  7. Livros  (2)
  8. Reports  (2)
  9. Archival Material / Manuscripts  (1)
  10. Dissertações  (1)
  11. Mais opções open sub menu

Assunto 

  1. Science & Technology  (710.195)
  2. Life Sciences & Biomedicine  (673.219)
  3. Humans  (520.252)
  4. Female  (439.441)
  5. Animals  (342.288)
  6. Middle Aged  (291.018)
  7. Adult  (228.295)
  8. Biological And Medical Sciences  (227.231)
  9. Aged  (220.229)
  10. Medical Sciences  (190.484)
  11. Rats  (167.915)
  12. Mice  (119.152)
  13. Pharmacology & Pharmacy  (108.210)
  14. Treatment Outcome  (86.168)
  15. Neurosciences & Neurology  (82.640)
  16. Aged, 80 And Over  (76.233)
  17. Cardiovascular System & Cardiology  (75.740)
  18. Pharmacology. Drug Treatments  (73.571)
  19. Oncology  (73.207)
  20. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1964  (70)
  2. 1964Até1978  (10.938)
  3. 1979Até1993  (48.456)
  4. 1994Até2009  (274.283)
  5. Após 2009  (449.493)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (778.293)
  2. Japonês  (147.328)
  3. Português  (1.779)
  4. Espanhol  (1.414)
  5. Alemão  (1.340)
  6. Francês  (1.084)
  7. Chinês  (704)
  8. Russo  (608)
  9. Norueguês  (318)
  10. Holandês  (287)
  11. Italiano  (168)
  12. Turco  (110)
  13. Polonês  (107)
  14. Dinamarquês  (73)
  15. Coreano  (55)
  16. Sueco  (50)
  17. Serbian  (48)
  18. Hebraico  (39)
  19. Tcheco  (32)
  20. Croatian  (28)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.